New Medicare Drug Benefit’s Impact on States and Low-Income Beneficiaries

New Medicare Drug Benefit’s Impact on States and Low-Income Beneficiaries

The recently signed Medicare prescription drug bill transfers responsibility for providing prescription drug coverage to dual-eligible beneficiaries from Medicaid to Medicare and creates a new subsidy program for low-income Medicare beneficiaries. These changes will have a major impact on state Medicaid programs both fiscally and administratively and it will also mean major changes for low-income beneficiaries’ drug coverage.

icon_presentations.gif Presentation: Medicare Prescription Drugs and Low-Income Beneficiaries
Implications of the New Medicare Law for Dual Eligibles: 10 Key Questions and Answers
Implications of the New Medicare Prescription Drug Benefit for State Medicaid Budgets
Summary of Low-Income Subsidy Program in Final Medicare Bill
Coordinating Medicaid and Medicare Prescription Drug Coverage: Findings from a Focus Group Discussion with Medicaid Directors
Dual Eligibles in Nursing Facilities and Medicare Drug Coverage
View a webcast of a policy briefing on this topic

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.